COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

BIOBAT INC
BROOKLYN, NY · EIN 453533828 · Form 990 · FY2024 · NTEE S31 · Community Improvement · Medium ($1M-$10M)
revenue
$2.0M
expenses
$3.3M
net assets
$24.4M
employees
0
volunteers
10
program ratio
85%
mission · from form 990

DEVELOP SPACE FOR NEW & GROWING BIOPHARM TECH COMPANIES TO CREATE A 21ST CENTURY WORKING WATERFRONT.

profile · synthesized from sources

BIOBAT INC is a Brooklyn-based nonprofit focused on community improvement through the development of biopharmaceutical and technology infrastructure. The organization aims to create a 21st-century working waterfront by providing space for emerging and growing biopharmaceutical and tech companies. Its mission centers on fostering innovation and economic development in Brooklyn, NY.

named programs · 1 · from sources

What they call their work

Working Waterfront Development
Develops and manages laboratory and office space for biopharmaceutical and technology startups in Brooklyn, supporting innovation and job creation in the life sciences sector.
activities · 1 group

What they do

  • Research Facility Management 1 activity
    • Developing space for biopharmaceutical technology companies
      Provides infrastructure by developing facilities to support emerging and expanding biopharmaceutical technology companies, contributing to a modern working waterfront.
financials · form 990 · fy2024
revenue
Total revenue$1.98M
Contributions & grants$00%
Program service revenue$1.97M100%
Investment income$00%
Other revenue$8K
expenses
Total expenses$3.29M
Program expenses85%
Admin / overhead15%
Fundraising0%
Salaries & benefits$316K
Grants paid out$0
Largest expense lineFacilities
balance sheet
Total assets$24.49M
Cash$3.03M
Investments$0
Liabilities$133K
Net assets$24.35M
Liquid reserves11.1 mo
6 years on record · 2019–2024 · YoY revenue -43.2%
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 1
NameTitleHours/wkCompensation
THOMAS HALL EXECUTIVE DIRECTOR 40 $240K
board members · 10
  • CHRISTINA DEROSE — DIRECTOR
  • CHRISTINE PAGLIALUNGA — CHAIR
  • DAVID CHRISTINI PHD — DIRECTOR
  • DR WAYNE RILEY MD — VICE CHAIR
  • HAZEL BALABAN — DIRECTOR
  • JAMES GIBALDI — DIRECTOR
  • JOAN BARTOLOMEO — DIRECTOR
  • JOSHUA GONZALEZ — SECRETARY
  • MATTTHEW MROZ — DIRECTOR
  • PREM PREMSRIRUT MD PHD — DIRECTOR
strategies · 1

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Infrastructure-Enabled Biotech Incubation
    methodology: innovation-district-development
    By providing dedicated physical space in a redeveloped waterfront environment, we enable emerging biopharmaceutical companies to scale, because access to specialized infrastructure reduces barriers to innovation and supports economic development.